Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system, in which the immune system causes an inflammatory response that damages or destroys myelin, axons, and...
Eating disorders are serious but treatable conditions with the highest mortality rates among mental health disorders, accounting for approximately 10% to 15% of mental illness deaths. According to a...
Several drug treatments for COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are approved for use in Canada. This systematic review evaluated the efficacy...
Several drug treatments for COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are approved for use in Canada. This systematic review evaluated the efficacy...
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelets and an increase in bleeding risk. This Health Technology Assessment is a narrative review of 15 publications...
Canada's Drug Agency assessed the clinical effectiveness and safety of formal peer support programs for youth mental health to support decision-making about adopting, implementing, and evaluating...
People living in rural areas often face difficulties when accessing health care. Due to the challenges with providing care in rural areas, various strategies have been proposed and implemented to help...
Primary membranous nephropathy (PMN) is an autoimmune disease that commonly presents as nephrotic syndrome. The treatment goal of patients with PMN is to induce remission. Current treatment options...
eConsult (also known as e-Consultation, electronic consultation, or remote consultation) is a type of asynchronous telehealth (also known as store-and-forward) that connects primary care providers...
Please visit the Condition-Level Review on tuberculosis Repository of Evidence and Resources to explore the findings of the Condition Level Review to date. Tuberculosis (TB) is a highly infectious...